Market
What will be the impact of UK puberty blockers ban on NHS gender dysphoria services by end of 2025?
2
Resolution / Starting Odds
Increased demand for alternative treatments • 25%
No significant impact • 25%
Decreased demand for gender dysphoria services • 25%
Other • 25%
Reports or statements from NHS England or related healthcare watchdogs
Story
UK Government Announces Indefinite Ban on Puberty Blockers for Under-18s
Dec 11, 2024, 02:44 PM
The UK government has announced an indefinite ban on the prescription of puberty blockers for children under 18 with gender dysphoria, effective from January 1, 2025. This decision follows a temporary ban introduced in May 2024, which was based on the findings of the Cass Review that highlighted insufficient evidence regarding the safety of these medications. Health Secretary Wes Streeting made the announcement, stating that the ban would apply to all prescriptions outside of clinical trials. The move aims to prevent what experts have described as an 'unacceptable safety risk' to minors. The government is also working with NHS England to provide holistic support for patients and their families, while the ban extends to private UK-registered prescribers as well.
View original story
Similar markets
Inconclusive • 25%
Safe and effective • 25%
Trial not completed • 25%
Unsafe • 25%
No • 50%
Yes • 50%
Majority oppose the ban • 25%
Majority neutral/undecided • 25%
No clear majority • 25%
Majority support the ban • 25%
Proven unsafe • 25%
Inconclusive results • 25%
Proven ineffective • 25%
Proven safe and effective • 25%
Inconclusive outcome • 25%
Positive outcome • 25%
Trials not completed • 25%
Negative outcome • 25%
No • 50%
Yes • 50%
Ban is lifted • 25%
Ban is modified • 25%
New restrictions added • 25%
Ban remains unchanged • 25%